DSIP, short for Delta Sleep-Inducing Peptide, is an experimental peptide that has been studied primarily for its possible effects on sleep, circadian rhythms, stress responses, pain, neuroendocrine function, and withdrawal symptoms. Unlike many recently popular research peptides, DSIP is not new. It was first isolated and characterized during the 1970s, and much of the human […]
Continue Reading
The GLOW peptide blend has become increasingly popular in peptide research because it combines several compounds associated with skin remodeling, collagen production, wound healing, tissue repair, hair-related research, and recovery. Unlike compounds such as BPC-157, semaglutide, or CJC-1295, however, GLOW is not a single peptide. “GLOW” is a commercial or research-market name used for a […]
Continue Reading
The combination of CJC-1295 and ipamorelin is frequently discussed in peptide research, fitness, recovery, and healthy-aging communities because both compounds influence the body’s growth hormone–IGF-1 axis, but they do so through different receptors. The underlying idea is relatively straightforward. CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, or GHRH. It stimulates GHRH receptors in […]
Continue Reading
CJC-1295 with DAC is a synthetic peptide designed to stimulate the body’s own production of growth hormone, or GH, and indirectly increase insulin-like growth factor 1, or IGF-1. It is commonly discussed in connection with research involving growth hormone secretion, recovery, body composition, muscle preservation, fat metabolism, sleep, healthy aging, and growth hormone deficiency. Unlike […]
Continue Reading
CJC-1295 without DAC is a synthetic peptide commonly discussed in connection with growth hormone release, recovery, sleep, body composition, muscle preservation, fat metabolism, and healthy-aging research. It belongs to a class of compounds known as growth hormone-releasing hormone analogues, or GHRH analogues. Rather than supplying growth hormone directly, these compounds are designed to stimulate the […]
Continue Reading
Cagrilintide peptide is one of the more interesting investigational peptides currently being developed for obesity, appetite regulation, weight management, and metabolic health. Unlike semaglutide, tirzepatide, and retatrutide, cagrilintide peptide is not primarily a GLP-1-based compound. Instead, it is a long-acting amylin analogue, meaning it is designed to mimic and enhance some of the biological effects […]
Continue Reading
